AH-7921*

AH-7921 is an opioid analgesic drug selective for the µ-opioid receptor, having around 80% the potency of morphine when administered orally. It was made a Prohibited Substance in Australia in May 2014. AH-7921 has been illegal to distribute in Israel since December 2013. In the UK, AH-7921 was included as a Class A drug in January 2015 as part of The Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2014. In Brazil, AH-7921 has been an illegal drug since May 2015. As of October 2015 AH-7921 is a controlled substance in China. AH-7921 is banned in the Czech Republic. In the United States, AH-7921 was placed into Schedule I of the Controlled Substances Act on May 16, 2016. The Canadian Controlled Drugs and Substances Act was amended in 2016 to include the substance as a Schedule I substance. Possession without legal authority can result in maximum 7 years imprisonment. Further, Health Canada amended the Food and Drug Regulations in May, 2016 to classify AH-7921 as a restricted drug. Only those with a law enforcement agency, person with an exemption permit or institutions with Minister's authorization may possess the drug in Canada.

Whole Blood
Post Mortem Blood
Urine
Oral Fluid
Hair
Meconium
Vitreous Humor
Tissue

Cross Reactivity

Analyte Compound
Cross Reactivity %
CR%
AH-7921
LOD: 0.53ng/ml
AH-7921 100
Nor-AH-7921
92.4
U-47700
<1

All data in the above table refers to our whole blood matrix.

Microplate Readers Available

Product ds2 7

DS2

  • Fully automated compact reader
  • Processes 100 samples per run
  • Ideal for routine drug detection


Product elx800 cutout tox logo

ELx800

  • Semi-automated robust microplate reader
  • Reads 96 wells in 30 seconds
  • Ideal for routine drug detection

UK: +44 (0)28 9442 2413
USA: +1 304 728 2890